ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.
| Image |  |
|---|---|
| Description | scientific article published on 9 May 2014 |
| Author/s |
author: Pietro Andreone Ola Weiland Beat Mullhaupt |
| Publication date | May 9, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |